Země: Austrálie
Jazyk: angličtina
Zdroj: Department of Health (Therapeutic Goods Administration)
leflunomide, Quantity: 100 mg
Southern Cross Pharma Pty Ltd
Leflunomide
Tablet, film coated
Excipient Ingredients: microcrystalline cellulose; povidone; colloidal anhydrous silica; crospovidone; maize starch; lactose monohydrate; magnesium stearate; titanium dioxide; hypromellose; macrogol 4000
Oral
3 tablet
(S4) Prescription Only Medicine
Treatment of active rheumatoid arthritis. The combined use of leflunomide with other disease modifying antirheumatic drugs (DMARDs) has not been adequately studied (see Precautions).
Visual Identification: White, oblong biconvex tablets with a scoreline on one side; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius
Licence status A
2014-04-02